Genesis Innovation Group

2013

Founded

8

Investments

United States

Offices

Venture Fund

Investor Type

About

Genesis Innovation Group is a U.S.-based medical device development firm dedicated to guiding innovators through the complex process of bringing new medical technologies to market. With a team boasting over a century of combined experience and more than 200 patents and innovations, Genesis offers a comprehensive suite of services spanning the entire product development lifecycle. Their expertise encompasses ideation, engineering, business and finance, manufacturing, regulatory and quality compliance, and market strategy and commercialization.

By partnering closely with entrepreneurs, researchers, manufacturers, distributors, and physicians, Genesis ensures that each project is executed with precision and efficiency, aiming to positively impact patient outcomes and establish itself as the most respected and sought-after medical device development company globally.

Investment Focus

Investment Stage

HQ Locations

Portfolio Companies

Embody, Nanochon, Imascap SAS, HAPPE Spine

Gepgraphic Focus

United States

Key Differentiators

Comprehensive service platform covering all stages of medical device development, Deep industry expertise with a team having over 200 patents and innovations, Strong partnerships with key stakeholders including researchers, manufacturers, distributors, and physicians, Commitment to positively impacting patient outcomes

Thypical Investment Size

Not publicly disclosed

Total Funds Raised

Not publicly disclosed

Visit Website

FinTech

SaaS

Seed

Series A

Series B

United States